Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FWW14
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,885
Award facts
- Contract value 100% obligated
- $27,885.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,885.44 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2-pen/mL format. This competitively awarded, firm fixed-price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a wide range of pharmaceutical products and medical supplies to military and veteran healthcare systems through the DLA Medical Supply Chain. Cosentyx is a biologic immunosuppressant used to treat autoimmune and inflammatory conditions, representing the type of specialty medication that AmerisourceBergen delivers to Defense Health Agency and other federal healthcare customers. The company's federal contracting history demonstrates consistent capability in fulfilling competitive procurement requirements for complex pharmaceutical commodities across multiple therapeutic domains, from specialty biologics to vaccines and generic medications.
Quick answers
Who was awarded contract SPE2DB25FWW14?
SPE2DB25FWW14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FWW14 worth?
The government has obligated $27,885 on SPE2DB25FWW14.
Is contract SPE2DB25FWW14 an order under another contract?
Yes. SPE2DB25FWW14 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWW14 competed?
The extent of competition for SPE2DB25FWW14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award